At the intersection of technology and expert support and consultative services is the comprehensive solution of Inteliquet.
CANCER CENTERS
Transforming the Patient Enrollment Journey
Enabling Cancer Centers
with Technology & Insights
OncWeb™ is powerful and user-friendly AI-enhanced technology designed to harness real world patient data and streamline critical steps in the patient enrollment journey. With OncWeb, you can:
- Better understand your patient population and predict the number of eligible patients you may have for trials
- Identify eligible patients with greater precision and at the time of diagnosis, using proprietary parsers that ingest, normalize and analyze unstructured data beyond the EMR, such as progress notes, labs, stage of disease, tumor type and biomarker data
- Store protected patient data behind your firewall or leverage our secure, HIPAA-compliant cloud-based environment
- Enable efficient trial feasibility, protocol digitization, prescreening, matching, and recruitment efforts with user-friendly OncWeb applications
- Utilize complimentary support services after the successful deployment of the platform
Trial Connection
Inteliquet is agnostic to the types of trials we support. Whether you are considering conducting a sponsor, investigator initiated, or NCI trial, our Clinical Engagement Specialists and advanced technology will support you in working through each critical step of the patient enrollment journey.
Ingestion & Normalization of Patient Data
Inteliquet’s proprietary NLP and parsing technology consumes structured and unstructured data types from disparate sources for easier ingestion, aggregation and normalization of relevant patient data. This unstructured patient data includes biomarker results, which are critical data points used in matching patients to complex oncology trials. Inteliquet parsers currently synthesize greater than 450 biomarkers and this number is rapidly growing.
Trial Feasibility
OncWeb’s trial feasibility application, Inteliquery,™ helps cancer centers rapidly and more accurately assess patient populations. Inteliquet’s technology dramatically reduces the time it takes cancer centers to gather the data to complete FSQs, while increasing the specificity, clarity, and understanding of patient populations. Cancer centers can select trials with greater confidence of their ability to enroll patients and thereby reach targets for their research program.
Protocol Digitization
Inteliquet’s technology has been designed to deeply digitize clinical protocols. We have a team of trial transcriptionists who digitize all protocols for cancer centers. Our transcriptionists are uniquely experienced and qualified to interpret trial eligibility criteria for cancer protocols, define statements that query the data and complete the trial digitization process. This complimentary service offered to Consortium partners reduces the burden to research staff, while providing them with accurate information to predict the success of patient enrollment into trials.
Patient Matching
OncWeb’s patient matching application, Inteliscreen, finds potentially eligible patients for trials – with greater precision and efficiency. Through natural language processing technology, and proprietary parsers, Inteliquet can ingest, aggregate and normalize various sources of unstructured patient data beyond the EMR, such as biomarker, lab and histology reports and progress notes. The power of Inteliquet’s parsing ability is strong and can identify a significantly greater number of trial-eligible patients. Lists of trial-eligible patients are curated for pre-screening and pre-vetting efforts.
Patient Pre-screening & Pre-vetting
Dedicated Clinical Engagement Specialists provide upon request support to help research staff fast-track the patient pre-screening and pre-vetting process. This team of specialized staff, understand the work necessary to confirm patients identified for a trial, which allows your staff and principal investigators to quickly determine whether to offer the study as a clinical care option for your patient.
Patient Consent & Enrollment
Physicians now have clinical trial options to present to vetted patients. The pathway to this final step in the enrollment journey has been streamlined and a greater number of patients were identified for the vetting process, using the power of OncWeb to harness deep patient data. Access to clinical trials with potential for clinical benefit has been attained for more patients.
ACCELERATING THE JOURNEY TO PATIENT
ENROLLMENT, WITH SPEED, EFFICIENCY AND PRECISION
TAP THE ICONS
Trial
Connection
Ingestion &
Normalization
of Patient Data
Trial
Feasibility
Protocol
Digitalization
Patient
Matching
Patient
Pre-screening
& Pre-vetting
Patient Consent
& Enrollment
CLICK THE ICONS ABOVE
For both sponsor companies and clinical researchers, the most critical step in the clinical trial lifecycle is achieving patient enrollment. Inteliquet provides tools and support services for cancer research centers to accelerate this journey. With a sharp understanding of cancer trial operations, our experienced team deploys advanced technology designed to reduce the burden of feasibility and patient matching on research and administrative staff.
Trial Connection
Inteliquet is agnostic to the types of trials we support. Whether you are considering conducting a sponsor, investigator initiated, or NCI trial, our Clinical Engagement Specialists and advanced technology will support you in working through each critical step of the patient enrollment journey.
Ingestion & Normalization of Patient Data
Inteliquet’s proprietary NLP and parsing technology consumes structured and unstructured data types from disparate sources for easier ingestion, aggregation and normalization of relevant patient data. This unstructured patient data includes biomarker results, which are critical data points used in matching patients to complex oncology trials. Inteliquet parsers currently synthesize greater than 450 biomarkers and this number is rapidly growing.
Trial Feasibility
OncWeb’s trial feasibility application, Inteliquery,™ helps cancer centers rapidly and more accurately assess patient populations. Inteliquet’s technology dramatically reduces the time it takes cancer centers to gather the data to complete FSQs, while increasing the specificity, clarity, and understanding of patient populations. Cancer centers can select trials with greater confidence of their ability to enroll patients and thereby reach targets for their research program.
Protocol Digitization
Inteliquet’s technology has been designed to deeply digitize clinical protocols. We have a team of trial transcriptionists who digitize all protocols for cancer centers. Our transcriptionists are uniquely experienced and qualified to interpret trial eligibility criteria for cancer protocols, define statements that query the data and complete the trial digitization process. This complimentary service offered to Consortium partners reduces the burden to research staff, while providing them with accurate information to predict the success of patient enrollment into trials.
Patient Matching
OncWeb’s patient matching application, Inteliscreen, finds potentially eligible patients for trials – with greater precision and efficiency. Through natural language processing technology, and proprietary parsers, Inteliquet can ingest, aggregate and normalize various sources of unstructured patient data beyond the EMR, such as biomarker, lab and histology reports and progress notes. The power of Inteliquet’s parsing ability is strong and can identify a significantly greater number of trial-eligible patients. Lists of trial-eligible patients are curated for pre-screening and pre-vetting efforts.
Patient Pre-screening & Pre-vetting
Dedicated Clinical Engagement Specialists provide upon request support to help research staff fast-track the patient pre-screening and pre-vetting process. This team of specialized staff, understand the work necessary to confirm patients identified for a trial, which allows your staff and principal investigators to quickly determine whether to offer the study as a clinical care option for your patient.
Patient Consent & Enrollment
Physicians now have clinical trial options to present to vetted patients. The pathway to this final step in the enrollment journey has been streamlined and a greater number of patients were identified for the vetting process, using the power of OncWeb to harness deep patient data. Access to clinical trials with potential for clinical benefit has been attained for more patients.
TESTIMONIALS
